Is Axcella Health Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 2 Wall Street analysts covering (NASDAQ: AXLA) stock is to Hold AXLA stock.
Out of 2 analysts, 0 (0%) are recommending AXLA as a Strong Buy, 0 (0%) are recommending AXLA as a Buy, 2 (100%) are recommending AXLA as a Hold, 0 (0%) are recommending AXLA as a Sell, and 0 (0%) are recommending AXLA as a Strong Sell.
What is AXLA's forecast return on equity (ROE) for 2023-2026?
(NASDAQ: AXLA) forecast ROE is N/A, which is considered weak.
What is AXLA's Price Target?
According to 1 Wall Street analyst that have issued a 1 year AXLA price target, the average AXLA price target is $2.00, with the highest AXLA stock price forecast at $2.00 and the lowest AXLA stock price forecast at $2.00.
The Wall Street analyst predicted that Axcella Health's share price could reach $2.00 by Dec 16, 2023. The average Axcella Health stock price prediction forecasts a potential upside of 447.95% from the current AXLA share price of $0.37.
What is AXLA's forecast return on assets (ROA) for 2023-2026?
(NASDAQ: AXLA) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 0.12%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.